Aller au contenu principal
2019 erratum

Correction to Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain

1Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Le résumé fourni par la source

ADVERTISEMENT RETURN TO ISSUEPREVAddition/CorrectionNEXTORIGINAL ARTICLEThis notice is a correctionCorrection to Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of PainGuanglin Luo*Guanglin LuoMore by Guanglin Luohttp://orcid.org/0000-0002-9465-3330, Ling ChenLing ChenMore by Ling Chen, Amy EastonAmy EastonMore by Amy Easton, Amy NewtonAmy NewtonMore by Amy Newton, Clotilde BourinClotilde BourinMore by Clotilde Bourin, Eric ShieldsEric ShieldsMore by Eric Shields, Kathy MosureKathy MosureMore by Kathy Mosure, Matthew G. SoarsMatthew G. SoarsMore by Matthew G. Soars, Ronald J. KnoxRonald J. KnoxMore by Ronald J. Knox, Michele MatchettMichele MatchettMore by Michele Matchett, Rick L. PieschlRick L. PieschlMore by Rick L. Pieschl, Debra J. Post-MunsonDebra J. Post-MunsonMore by Debra J. Post-Munson, Shuya WangShuya WangMore by Shuya Wang, James HerringtonJames HerringtonMore by James Herrington, John GraefJohn GraefMore by John Graef, Kimberly NewberryKimberly NewberryMore by Kimberly Newberry, Digavalli V. SivaraoDigavalli V. SivaraoMore by Digavalli V. Sivarao, Arun SenapatiArun SenapatiMore by Arun Senapati, Linda J. BristowLinda J. BristowMore by Linda J. Bristow, Nicholas A. MeanwellNicholas A. MeanwellMore by Nicholas A. Meanwell, Lorin A. ThompsonLorin A. ThompsonMore by Lorin A. Thompson, and Carolyn DzierbaCarolyn DzierbaMore by Carolyn DzierbaCite this: J. Med. Chem. 2019, 62, 4, 2213Publication Date (Web):February 8, 2019Publication History Published online8 February 2019Published inissue 28 February 2019https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00202https://doi.org/10.1021/acs.jmedchem.9b00202correctionACS PublicationsCopyright © 2019 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views1472Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (186 KB) Get e-Alertsclose Get e-Alerts

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.

Titre Crossref
Correction to Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na<sub>V</sub>1.7 Inhibitors for the Treatment of Pain
Date Crossref
08/02/2019
Éditeur
American Chemical Society (ACS)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les sujets associés

Synthesis and Reactivity of Sulfur-Containing Compounds

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.